1. Home
  2. Rural Health
  3. Opioid Response
  4. RCORP-Neonatal Abstinence Syndrome

RCORP-Neonatal Abstinence Syndrome

The purpose of RCORP-NAS is to reduce the incidence and impact of Neonatal Abstinence Syndrome (NAS) in rural communities by improving systems of care, family supports, and social determinants of health.

RCORP-NAS award recipients will receive up to $500,000 over a three-year period of performance to achieve the following goals:

  1. Reduce structural-and systems-level barriers (e.g., transportation challenges, limited workforce, reimbursement issues, etc.); to
    • Increase access to behavioral health care, especially substance use disorders, including opioid use disorder (SUD/OUD), services for rural pregnant and postpartum persons and their families; and
    • Address community risk factors and social determinants of health.
  2. Strengthen the quality and sustainability of behavioral health care services for rural pregnant and postpartum persons and their families by implementing coordinated, evidence-based, trauma-informed, family-centered SUD/OUD and other services. RCORP-NAS recipients will implement activities that benefit pregnant people and people  of childbearing age who have a history of, or who are at risk for, SUD/OUD and their children, families, and caregivers who reside in rural areas. Applicants are encouraged to include populations that have historically suffered from poorer health outcomes, health disparities, and other inequities as compared to the rest of the population.

Applicant resources

Grant recipients

FY23 Cohort (41 Grantees): List of RCORP-NAS grantees

Contact us

Questions about HRSA's efforts to combat the opioid epidemic in rural communities? Email us at

Date Last Reviewed: